Related Experiment Video
Updated: Jan 13, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
Toward In Situ Dynamics of DNA-Bound Full-Length p53 Tetramer
Özlem Demir1, Emilia P Barros1, Rommie E Amaro2
1Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, San Diego, California 92093, United States.
Restoring tumor suppressor p53 (also known as TP53) activity is a promising cancer therapy strategy. This study models the full-length p53 tetramer, revealing its DNA interactions and dynamics, and identifying new potential drug targets.
Area of Science:
- Molecular Biology
- Structural Biology
- Computational Biology
Background:
- p53 is a critical human tumor suppressor, frequently mutated in cancer.
- Restoring p53 function is a key goal for novel cancer therapies.
- Understanding full-length p53 (fl-p53) structure and dynamics is essential for therapeutic development.
Purpose of the Study:
- To generate the first model of the wild-type (WT) full-length p53 tetramer bound to DNA.
- To elucidate the conformational landscape of WT p53 and cancer mutants using molecular dynamics.
- To identify potential therapeutic targets by analyzing p53 dynamics and interactions.
Main Methods:
- Integrative molecular modeling combining crystal structures and computational techniques.
- Microsecond timescale molecular dynamics simulations on the Anton2 supercomputer.
- Markov state model (MSM) framework for analyzing conformational dynamics.
Main Results:
- A detailed model of the DNA-bound fl-p53 tetramer was generated, revealing DNA bending and compact complex formation.
- WT fl-p53 exhibited a unique quaternary DNA-binding domain (DBD) organization not seen in mutants.
- Differential dynamics were observed between inner and outer DBDs, and a cryptic pocket in loop 6 (L6) was identified.
Conclusions:
- The study provides unprecedented insights into the structural dynamics of DNA-bound fl-p53.
- Cancer mutations (Y220C, G245S) alter p53 tetramer organization and dynamics.
- The identified L6 cryptic pocket represents a potential new target for p53-based cancer therapies.
Related Concept Videos
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
Restarting Stalled Replication Forks

